|
Chromos Molecular Systems |
|
|
220 - 980 W 1st Street, Mail Box # 8 North Vancouver, BC V7P 3N4 Canada phone: 604 415 7100 fax:604 980 2501
|
|
| Symbol |
CHR |
| Exchange |
TSE |
| Founded |
0 |
| Employees |
|
|
|
| www.chromos.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Immune and gene-based cell therapies and cell lines for biopharmaceutical production. |
 |
| Management |
| Roger Flowerdew, President, Chief Executive Officer and Director; Jeff Charpentier, Vice President Finance, Chief Financial Offer |
| |
|
|
|
|
|
|
|
| Keywords |
| cancer, infectious diseases, genetic disorders, gene, immune, biopharmaceutical, InfectiousDisease |
|
|
|
| Description |
|
Chromos Molecular Systems develops immune and gene-based cell therapies and engineers cell lines for biopharmaceutical production. |
 |
| Technology / Differentiation |
| Chromos Molecular Systems is using its Artificial Chromosome Expression (ACE) System and Rapid Expansion Method (REM) technologies develop innovative therapies. |
 |
 |
|
|
|
|
|
|